» Articles » PMID: 28422987

Systematic Review and Meta-analysis Shows a Specific Micronutrient Profile in People with Down Syndrome: Lower Blood Calcium, Selenium and Zinc, Higher Red Blood Cell Copper and Zinc, and Higher Salivary Calcium and Sodium

Overview
Journal PLoS One
Date 2017 Apr 20
PMID 28422987
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Different metabolic profiles as well as comorbidities are common in people with Down Syndrome (DS). Therefore it is relevant to know whether micronutrient levels in people with DS are also different. This systematic review was designed to review the literature on micronutrient levels in people with DS compared to age and sex-matched controls without DS. We identified sixty nine studies from January 1967 to April 2016 through main electronic medical databases PubMed, Scopus, and Web of knowledge. We carried out meta-analysis of the data on four essential trace elements (Cu, Fe, Se, and Zn), six minerals (Ca, Cl, K, Mg, Na, and P), and five vitamins (vitamin A, B9, B12, D, and E). People with DS showed lower blood levels of Ca (standard mean difference (SMD) = -0.63; 95% confidence interval (CI): -1.16 to -0.09), Se (SMD = -0.99; 95% CI: -1.55 to -0.43), and Zn (SMD = -1.30; 95% CI: -1.75 to -0.84), while red cell levels of Zn (SMD = 1.88; 95% CI: 0.48 to 3.28) and Cu (SMD = 2.77; 95% CI: 1.96 to 3.57) were higher. They had also higher salivary levels of Ca (SMD = 0.85; 95% CI: 0.38 to 1.33) and Na (SMD = 1.04; 95% CI: 0.39 to 1.69). Our findings that micronutrient levels are different in people with DS raise the question whether these differences are related to the different metabolic profiles, the common comorbidities or merely reflect DS.

Citing Articles

Where do neurodevelopmental conditions fit in transdiagnostic psychiatric frameworks? Incorporating a new neurodevelopmental spectrum.

Michelini G, Carlisi C, Eaton N, Elison J, Haltigan J, Kotov R World Psychiatry. 2024; 23(3):333-357.

PMID: 39279404 PMC: 11403200. DOI: 10.1002/wps.21225.


Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effect.

Ramacieri G, Locatelli C, Semprini M, Pelleri M, Caracausi M, Piovesan A Front Immunol. 2024; 15:1362501.

PMID: 38694501 PMC: 11061464. DOI: 10.3389/fimmu.2024.1362501.


Blood tests and use of nutritional supplements in a cohort of Brazilian children with trisomy 21.

Miyasaki A, Radigonda J, Klein R, Moreira E J Pediatr (Rio J). 2023; 99(6):610-616.

PMID: 37353208 PMC: 10594004. DOI: 10.1016/j.jped.2023.05.009.


A quest for genetic causes underlying signaling pathways associated with neural tube defects.

Rai S, Leydier L, Sharma S, Katwala J, Sahu A Front Pediatr. 2023; 11:1126209.

PMID: 37284286 PMC: 10241075. DOI: 10.3389/fped.2023.1126209.


The accumulation of copper in the brain of Down syndrome promotes oxidative stress: possible mechanism underlying cognitive impairment.

Ishihara K J Clin Biochem Nutr. 2022; 71(1):16-21.

PMID: 35903608 PMC: 9309086. DOI: 10.3164/jcbn.21-155.


References
1.
van Trotsenburg A, Vulsma T, Rutgers van Rozenburg-Marres S, van Baar A, Ridder J, Heymans H . The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab. 2005; 90(6):3304-11. DOI: 10.1210/jc.2005-0130. View

2.
Matin M, SYLVESTER P, Edwards D, Dickerson J . Vitamin and zinc status in Down syndrome. J Ment Defic Res. 1981; 25(Pt 2):121-6. DOI: 10.1111/j.1365-2788.1981.tb00099.x. View

3.
Biselli J, Zampieri B, Goloni-Bertollo E, Haddad R, Fonseca M, Eberlin M . Genetic polymorphisms modulate the folate metabolism of Brazilian individuals with Down syndrome. Mol Biol Rep. 2012; 39(10):9277-84. DOI: 10.1007/s11033-012-1629-5. View

4.
Wachowicz B, Kdziora J . [Low blood iron content in children with Down's syndrome]. Endokrynol Pol. 1974; 25(1):9-13. View

5.
Rabiei M, Shenavar Masooleh I, Kazemnejad Leyli E, Nikoukar L . Salivary calcium concentration as a screening tool for postmenopausal osteoporosis. Int J Rheum Dis. 2013; 16(2):198-202. DOI: 10.1111/1756-185X.12003. View